A new study published in Cell Death Discovery has identified a promising strategy to overcome one of the most stubborn forms ...

Eikon Therapeutics, Inc. (Nasdaq: EIKN) (“Eikon”), a late-stage clinical biopharmaceutical company dedicated to developing innovative medicines to address serious unmet medical needs, today announced ...

A new study shows that dihydrotestosterone boosts NFκB signaling, monocyte migration, and endothelial detachment during ...

In a recent study published by Nature Communications, researchers uncovered a previously unknown method by which androgen-activated androgen receptors (ARs) increase fucosyltransferase 4 (FUT4) ...

Many treatments for prostate cancer, one of the most common cancers in men, target a protein called the androgen receptor, ...

A poorly characterized protein, historically thought to be a chaperone or enzyme, may actually be a key player in prostate cancer. In a systematic CRISPR screen, scientists from Arc Institute, UCSF, ...

Please provide your email address to receive an email when new articles are posted on . LPCN 1148 increased Skeletal Muscle Index at L3 spine level by the equivalent of 7.9%. Treatment also resulted ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. At week 24, LPCN 1148 significantly improved the ...

Estrogen and androgens both support tear production and the vital lipid (oil) layer secreted by the eyelids that keeps tears ...